130 related articles for article (PubMed ID: 28640312)
1. Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
Sanna D; Ugone V; Micera G; Buglyó P; Bíró L; Garribba E
Dalton Trans; 2017 Jul; 46(28):8950-8967. PubMed ID: 28640312
[TBL] [Abstract][Full Text] [Related]
2. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
Le M; Rathje O; Levina A; Lay PA
J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
[TBL] [Abstract][Full Text] [Related]
3. Speciation of potential anti-diabetic vanadium complexes in real serum samples.
Sanna D; Ugone V; Serra M; Garribba E
J Inorg Biochem; 2017 Aug; 173():52-65. PubMed ID: 28499214
[TBL] [Abstract][Full Text] [Related]
4. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies.
Sanna D; Ugone V; Pisano L; Serra M; Micera G; Garribba E
J Inorg Biochem; 2015 Dec; 153():167-177. PubMed ID: 26281973
[TBL] [Abstract][Full Text] [Related]
5. Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.
Lodyga-Chruscinska E; Sanna D; Garribba E; Micera G
Dalton Trans; 2008 Sep; (36):4903-16. PubMed ID: 18766223
[TBL] [Abstract][Full Text] [Related]
6. Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes.
Sanna D; Serra M; Micera G; Garribba E
Inorg Chem; 2014 Feb; 53(3):1449-64. PubMed ID: 24437949
[TBL] [Abstract][Full Text] [Related]
7. Characterization and biotransformation in the plasma and red blood cells of V(IV)O(2+) complexes formed by ceftriaxone.
Sanna D; Fabbri D; Serra M; Buglyó P; Bíró L; Ugone V; Micera G; Garribba E
J Inorg Biochem; 2015 Jun; 147():71-84. PubMed ID: 25601642
[TBL] [Abstract][Full Text] [Related]
8. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
Narla RK; Chen CL; Dong Y; Uckun FM
Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
[TBL] [Abstract][Full Text] [Related]
9. Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum.
Sanna D; Bíró L; Buglyó P; Micera G; Garribba E
J Inorg Biochem; 2012 Oct; 115():87-99. PubMed ID: 22926028
[TBL] [Abstract][Full Text] [Related]
10. A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding.
Gonçalves G; Tomaz I; Correia I; Veiros LF; Castro MM; Avecilla F; Palacio L; Maestro M; Kiss T; Jakusch T; Garcia MH; Pessoa JC
Dalton Trans; 2013 Sep; 42(33):11841-61. PubMed ID: 23677414
[TBL] [Abstract][Full Text] [Related]
11. New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum.
Sanna D; Micera G; Garribba E
Inorg Chem; 2010 Jan; 49(1):174-87. PubMed ID: 19947643
[TBL] [Abstract][Full Text] [Related]
12. Speciation of the Potential Antitumor Agent Vanadocene Dichloride in the Blood Plasma and Model Systems.
Sanna D; Ugone V; Micera G; Pivetta T; Valletta E; Garribba E
Inorg Chem; 2015 Sep; 54(17):8237-50. PubMed ID: 26280599
[TBL] [Abstract][Full Text] [Related]
13. Chemical speciation of insulinomimetic VO(IV) complexes of pyridine-N-oxide derivatives: binary and ternary systems.
Kiss E; Kawabe K; Tamura A; Jakusch T; Sakurai H; Kiss T
J Inorg Biochem; 2003 Jun; 95(2-3):69-76. PubMed ID: 12763650
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of V(IV)O complexes of picolinate and pyrazine derivatives. Behavior in the solid state and aqueous solution and biotransformation in the presence of blood plasma proteins.
Koleša-Dobravc T; Lodyga-Chruscinska E; Symonowicz M; Sanna D; Meden A; Perdih F; Garribba E
Inorg Chem; 2014 Aug; 53(15):7960-76. PubMed ID: 25013935
[TBL] [Abstract][Full Text] [Related]
15. Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin.
Sanna D; Ugone V; Micera G; Garribba E
Dalton Trans; 2012 Jun; 41(24):7304-18. PubMed ID: 22576640
[TBL] [Abstract][Full Text] [Related]
16. On the transport of vanadium in blood serum.
Sanna D; Micera G; Garribba E
Inorg Chem; 2009 Jul; 48(13):5747-57. PubMed ID: 19514735
[TBL] [Abstract][Full Text] [Related]
17. A unique dinuclear mixed V(V) oxo-peroxo complex in the structural speciation of the ternary V(V)-peroxo-citrate system. potential mechanistic and structural insight into the aqueous synthetic chemistry of dinuclear V(V)-citrate species with H2O2.
Kaliva M; Gabriel C; Raptopoulou CP; Terzis A; Voyiatzis G; Zervou M; Mateescu C; Salifoglou A
Inorg Chem; 2011 Nov; 50(22):11423-36. PubMed ID: 22029259
[TBL] [Abstract][Full Text] [Related]
18. V
Sanna D; Ugone V; Sciortino G; Buglyó P; Bihari Z; Parajdi-Losonczi PL; Garribba E
Dalton Trans; 2018 Feb; 47(7):2164-2182. PubMed ID: 29327005
[TBL] [Abstract][Full Text] [Related]
19. Ternary complex formation between VO(IV)-picolinic acid or VO(IV)-6-methylpicolinic acid and small blood serum bioligands.
Kiss E; Garribba E; Micera G; Kiss T; Sakurai H
J Inorg Biochem; 2000 Jan; 78(2):97-108. PubMed ID: 10766332
[TBL] [Abstract][Full Text] [Related]
20. Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity.
D'Cruz OJ; Uckun FM
Expert Opin Investig Drugs; 2002 Dec; 11(12):1829-36. PubMed ID: 12457442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
